Sight Sciences, Inc.
SGHT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.37 | 0.12 | -0.19 | -0.17 |
| FCF Yield | -12.46% | -19.12% | -13.17% | -6.39% |
| EV / EBITDA | -2.23 | -3.00 | -5.40 | -10.63 |
| Quality | ||||
| ROIC | -39.69% | -36.51% | -42.57% | -19.29% |
| Gross Margin | 85.50% | 85.34% | 82.67% | 82.41% |
| Cash Conversion Ratio | 0.43 | 0.85 | 0.88 | 0.83 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.84% | 18.30% | 37.17% | 27.99% |
| Free Cash Flow Growth | 52.61% | 37.64% | -44.20% | -61.06% |
| Safety | ||||
| Net Debt / EBITDA | 1.74 | 2.08 | 1.86 | 3.96 |
| Interest Coverage | -10.84 | -10.59 | -18.80 | -11.79 |
| Efficiency | ||||
| Inventory Turnover | 1.83 | 1.51 | 2.02 | 2.48 |
| Cash Conversion Cycle | 195.34 | 252.30 | 178.68 | 70.19 |